ROBERT SALZMAN: Open Payments
NPI 1629686845 · LAKELAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,999 in 147 payments from 27 companies in 2025. Trend: 2023 $997 · 2024 $2,348 · 2025 $2,999
Food & beverage: $2,777Education: $198Consulting: $25
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 25 | $519 |
| CSL Behring | 29 | $474 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $300 |
| AstraZeneca Pharmaceuticals LP | 9 | $290 |
| Novartis Pharmaceuticals Corporation | 12 | $213 |
| GENZYME CORPORATION | 9 | $183 |
| GlaxoSmithKline, LLC. | 6 | $118 |
| PFIZER INC. | 4 | $79 |
| Lilly USA, LLC | 4 | $75 |
| Amgen Inc. | 3 | $71 |
Products named: DUPIXENT, Andembry, CUVITRU, BREZTRI, Haegarda, Xolair, Xhance, FASENRA.
Industry payments across FL — which companies pay providers there.
